# Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma

> **NCT00006252** · PHASE2 · COMPLETED · sponsor: **Cancer and Leukemia Group B** · enrollment: 47 (actual)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **DRUG:** fludarabine phosphate
- **DRUG:** Cyclophosphamide
- **BIOLOGICAL:** PBSC
- **DRUG:** G-CSF
- **BIOLOGICAL:** Donor lymphocytes

## Key facts

- **NCT ID:** NCT00006252
- **Lead sponsor:** Cancer and Leukemia Group B
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2007-01
- **Final completion:** 2011-10
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2016-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006252, "Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00006252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*